Clinical Research

Farmalider S.A.

Address
Calle De La Granja 1 Planta 3

Sponsor Overview

assignment
10
sponsored trials
science
6
molecules
location_city
27
research centres
public
3
countries
person_search
45
investigators

Specializations

Musculoskeletal Pain and Hand Osteoarthritis

Farmalider S.A. sponsors clinical research in erosive osteoarthritis of the hands and erosive/inflammatory osteoarthritis, with a clear emphasis on pain relief, functional discomfort, and symptom control in affected hand joints.

  • Hand pain intensity
  • Erosive hand osteoarthritis
  • Inflammatory joint symptoms

The sponsor’s work in this area is centered on therapies aimed at reducing persistent pain in degenerative and inflammatory joint conditions.

Acute Pain and Postoperative Analgesia

The company supports studies in acute pain and moderate to severe somatic pain, including pain associated with dental procedures and postoperative recovery, reflecting a strong interest in short-term analgesic management.

  • Post-surgical pain
  • Dental extraction pain
  • Somatic pain relief

These trials focus on oral and intravenous analgesic options for rapidly controlling intense pain in clinical settings.

Combination Analgesics and Non-opioid Pain Therapy

Farmalider S.A. has an active research interest in fixed-dose combinations involving ibuprofen, tramadol, and paracetamol, with attention to both efficacy and tolerability in pain treatment.

  • Ibuprofen-tramadol combinations
  • Paracetamol-ibuprofen formulations
  • Analgesic safety

This therapeutic area includes oral suspensions, granules, and other formulations designed for pain control across different clinical contexts.

Healthy Volunteer Studies and Bioavailability

The sponsor also funds research in healthy volunteers to examine formulation characteristics, palatability, and comparative bioavailability of pain-related medicines and other therapeutic agents.

  • Formulation comparison
  • Oral suspension and granule products
  • Single-dose pharmacokinetic assessment

These studies extend to non-pain therapies such as tadalafil, broadening the sponsor’s formulation-focused research portfolio.

Sponsored Trials

Trial Name Country Status
An Open-Label Palatability Study of a Novel Orodispersible Paracetamol and Ibuprofen Formulation Following Single Oral Administration in Healthy VolunteersSpain SpainNot Recruiting
Comparative Bioavailability Study of Ibuprofen (Arginine) Granules Versus Espidifen® in Healthy Volunteers Under Fasting ConditionsSpain SpainNot Recruiting
Comparative Bioavailability Study of Paracetamol-Ibuprofen Oral Suspension in Healthy Volunteers Under Fasting ConditionsSpain SpainNot Recruiting
Comparative Bioavailability Study of Two Ibuprofen Arginate Formulations in Healthy Volunteers Under Fasting ConditionsSpain SpainNot Recruiting
Comparative Bioavailability Study of Two Ibuprofen Formulations in Healthy Volunteers Under Fasting ConditionsSpain SpainNot Recruiting
Efficacy and Safety Evaluation of Montelukast Versus Placebo in Patients with Erosive Hand Osteoarthritis: A Randomized, Double-Blind, Multicenter TrialItaly ItalyPortugal PortugalSpain SpainRecruiting
Evaluation of Intravenous Ibuprofen (Arginate)-Tramadol Hydrochloride Combination for Analgesic Efficacy in Acute Severe Postoperative Pain: A Phase III StudySpain SpainNot Recruiting
Evaluation of the Analgesic Efficacy and Safety of Ibuprofen Arginine and Tramadol Hydrochloride in Postoperative Dental Pain ManagementSpain SpainNot Recruiting
Phase II Randomized, Double-Blind, Dose-Finding Study of Montelukast in Erosive Hand Osteoarthritis PatientsSpain SpainNot Recruiting
Pilot randomized crossover comparative bioavailability study of tadalafil oral suspension versus film-coated tablets after single-dose administration in healthy male volunteersSpain SpainNot Recruiting

Data & Insights

science
Molecule Portfolio
Compounds under investigation
1
Exclusive Molecules
out of 6 total (17% not shared with other sponsors)

This sponsor works with 6 molecules, of which 1 is not being studied by other sponsors.

hub
Site Partnerships
Collaboration with research centres
30%
Return partnership rate
8 of 27 sites collaborated multiple times

This sponsor has worked with 27 sites across their trial portfolio.

Therapeutic Focus

  • 1.
    Not possible to specify8 trials
    220 other sponsors
  • 2.
    Musculoskeletal Diseases2 trials
    238 other sponsors
  • 3.
    Immune System Diseases1 trial
    322 other sponsors

Partnered Research Centres

27 centres
location_city
assignment523
Azienda Ospedaliera Universitaria Citta' Della Salute E Della Scienza Di Torino
Address
Via Cherasco 15, 10126 Turin
Learn morearrow_forward
location_city
assignment624
Azienda Ospedaliero Universitaria Careggi
Address
Largo Giovanni Alessandro Brambilla 3, 50134 Florence
Learn morearrow_forward
location_city
assignment41
Centro Hospitalar Do Baixo Vouga E.P.E. (CHBV E.P.E.)
Address
Avenida De Artur Ravara, 3814-501 Aveiro
Learn morearrow_forward
location_city
assignment944
Fundacion Para La Investigacion Biomedica Del Hospital Universitario La Paz
Address
Paseo De La Castellana 261, 28046 Madrid
Learn morearrow_forward
location_city
assignment579
Hospital Clinico San Carlos
Address
Calle Del Profesor Martin Lagos Sn, 28040 Madrid
Learn morearrow_forward
location_city
assignment58
Hospital De Santa Maria E.P.E.
Address
Avenida Professor Egas Moniz Piso 3, 1649-028 Lisbon
Learn morearrow_forward
Page 1 of 5

Want to get in touch with this sponsor?

Send a question and we'll pass it on to Farmalider S.A..

Need a custom report on this sponsor?

Competitive positioning, market entry, partnership opportunities — tell us the question.

Is something out of date?

Tell us what needs correcting and we'll update this profile.